Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomised controlled trials
Carolyn F. Deacon
Endocrinology and Metabolism
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomised controlled trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Dipeptidyl-Peptidase IV Inhibitors
100%
Randomized Controlled Trials
51%
Hypoglycemia
29%
Type 2 Diabetes Mellitus
22%
Phase III Clinical Trials
18%
Kidney Diseases
15%
General Practice
14%
Chronic Renal Insufficiency
13%
Hyperglycemia
13%
Hospitalization
11%
Heart Failure
11%
Cardiovascular Diseases
10%
Clinical Studies
10%
Insulin
10%
Safety
8%
Kidney
8%
Incidence
7%
Therapeutics
2%